Basit öğe kaydını göster

dc.contributor.authorSimsekoglu, Muhammed Fatih
dc.contributor.authorTalat, Zubeyr
dc.contributor.authorErozenci, Ahmet
dc.contributor.authorUslu, Ezel
dc.contributor.authorÇİTGEZ, Sinharib
dc.contributor.authorDEMİRDAĞ, Çetin
dc.contributor.authorÖNAL, Bülent
dc.contributor.authorKaleler, Islim
dc.date.accessioned2021-03-02T15:45:27Z
dc.date.available2021-03-02T15:45:27Z
dc.identifier.citationSimsekoglu M. F. , Kaleler I., ÖNAL B., DEMİRDAĞ Ç., ÇİTGEZ S., Uslu E., Erozenci A., Talat Z., "Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021
dc.identifier.issn1368-5031
dc.identifier.otherav_e6eb5264-3582-4bd6-8e82-c0378266618e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/1662
dc.identifier.urihttps://doi.org/10.1111/ijcp.13959
dc.description.abstractBackground Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy.
dc.language.isoeng
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectFamily Practice
dc.subjectPharmacology (medical)
dc.subjectFundamentals and Skills
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectPharmacy
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.titleDo urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID2504197


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster